Biocon trades in green on the bourses

06 Oct 2016 Evaluate

Biocon is currently trading at Rs. 959.50, up by 4.15 points or 0.43% from its previous closing of Rs. 955.35 on the BSE.

The scrip opened at Rs. 971.00 and has touched a high and low of Rs. 971.90 and Rs. 956.00 respectively. So far 99885 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 988.00 on 28-Sep-2016 and a 52 week low of Rs. 430.80 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 978.60 and Rs. 886.15 respectively. The current market cap of the company is Rs. 19160.00 crore.

The promoters holding in the company stood at 60.68%, while Institutions and Non-Institutions held 20.25% and 19.08% respectively.

Biocon is all set to launch new branded formulations of its own and introduce products licensed from others to treat diabetes and cancer in the coming months. In this regards, the company will also approach more doctors through field staff and use digital technologies to train doctors and bring awareness among patients.

Moreover, the company is in talks with prospective partners for in-licensing novel molecules to strengthen its portfolio. Further, the company is planning to launch two key biosimilars bevacizumab and adalimumab in India in the near future.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

 

 

 

Biocon Share Price

387.15 2.50 (0.65%)
17-Dec-2025 13:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.00
Dr. Reddys Lab 1269.30
Cipla 1493.70
Zydus Lifesciences 917.70
Lupin 2110.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×